ACE-031 and Exemestane Interaction

Synergistic
Mechanism-based 46% confidence

ACE-031 and Exemestane have a synergistic interaction with 46% confidence. Exemestane supports hormonal recovery from suppression caused by ACE-031. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. Both compounds affect the gonads and heart and liver and pituitary, so monitoring these systems is recommended.

Compound Profiles

ACE-031

Myostatin Inhibitor | Experimental Muscle Growth

ACE-031 acts as a ligand trap for members of the TGF-beta superfamily. By mimicking the extracellular domain of the ActRIIB receptor, it intercepts myostatin (GDF-8), activin A, activin B, and GDF-11 before they can bind cell-surface receptors and activate Smad2/3 signaling.

Half-life: 12-15 days Typical dose: 0.5-3 mg/kg IV every 2 weeks (clinical research doses only) growth hormone, anabolic
actriibmyostatintgf beta androgenicanticoagulantblood pressure raisinghpta suppressive
View full profile

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Half-life: ~24 hours Typical dose: 12.5mg EOD or 25mg E3D (estrogen management) pct, anabolic
androgen receptoraromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Combined Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pituitary
low

Shared Safety Flags

2x 2 androgenic compounds (ACE-031, Exemestane). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 HPTA-suppressive compounds (ACE-031, Exemestane). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (ACE-031, Exemestane). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (ACE-031, Exemestane). Monitor accordingly.

Frequently Asked Questions

Can I take ACE-031 with Exemestane?

Yes, ACE-031 and Exemestane can generally be taken together. Exemestane supports hormonal recovery from suppression caused by ACE-031. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life.

Is ACE-031 and Exemestane safe together?

Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: androgenic, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between ACE-031 and Exemestane?

Exemestane supports hormonal recovery from suppression caused by ACE-031. Standard protocol — begin PCT after the suppressive compound has cleared based on its half-life. This assessment has 46% confidence and is inferred from pharmacological mechanism analysis.

How should I time ACE-031 and Exemestane?

ACE-031 has a half-life of 12-15 days and Exemestane has a half-life of ~24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: ACE-031 vs Exemestane

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.